Metabolism and fat storage -
Another pathway that may be involved in the FFA- induced impairment in glucose metabolism is oxidative stress. FFAs can directly increase reactive oxygen species ROS via peroxidation reactions and via mitochondrial production FFAs can also indirectly increase ROS via hexosamine biosynthetic products Recent data obtained in collaboration with Dr.
Fantus University of Toronto and co-workers suggests that iv infusion of N -acetyl- l -cysteine NAC , an antioxidant, abolishes hyperglycemia and glucosamine-induced insulin resistance and prevents, in part, FFA-induced insulin resistance in rats Infusion of reduced glutathione, an antioxidant, partially prevented FFA-induced insulin resistance in humans The biochemical mechanisms of oxidative stress-induced insulin resistance are unknown; however, it is well known that ROS can affect both signal transduction and gene expression, perhaps via redox modification of critical molecules.
It is known that both oxidative stress and the glucosamine pathway can induce PKC activation. Perhaps linked to FFA-induced oxidative stress and PKC activation is the activation of IκB kinase β IKK-β , a serine-threonine kinase that phosphorylates the insulin receptor and IRSs, thus inhibiting their tyrosine kinase phosphorylation.
The latter pathway has recently been implicated in FFA-induced inhibition of insulin signaling and action, because high-dose salicylate, an inhibitor of IKK-β , prevented FFA-induced insulin resistance in skeletal muscle in vivo , and IKK-β-knockout mice did not exhibit altered skeletal muscle insulin signaling and action after lipid infusion , Also perhaps linked to oxidative stress and to synthesis of ceramides is the induction of inducible nitric oxide iNOS in muscle, which has recently been implicated in insulin resistance in the high-fat-fed rat By activating all the signaling pathways described above, FFA can indirectly influence gene expression FFAs and their eicosanoid derivatives can also directly affect gene expression by binding to PPARs These nuclear receptors induce genes of peroxisomal and mitochondrial fatty acid oxidation , thus potentially up-regulating the Randle cycle.
Paradoxically, however, PPAR activation increases muscle insulin sensitivity, presumably because of induction of uncoupling proteins, which dissipate intracellular energy and reduce intracellular triglycerides. This may be viewed as a protective mechanism whereby fat accumulation tends to be self-limited.
Fat accumulation also depends on the type of fatty acid. n-3 fatty acids, which preferentially activate PPARs, are associated with less muscle fat accumulation and increased insulin sensitivity compared with saturated fatty acids Fatty acid activation of PPARγ in the adipocyte, perhaps by increasing adipocyte insulin sensitivity and by stimulating adipogenesis, may also indirectly improve muscle insulin sensitivity in vivo by modulating a fat-derived signaling molecule or FFA flux from adipose to muscle tissue Most of the in vivo literature regarding the effect of FFA on hepatic glucose metabolism refers to the acute effect of Intralipid and heparin on glucose production.
Intralipid plus heparin increases FFA as well as glycerol, which is a gluconeogenic precursor, and in almost all of the studies, a glycerol control was not performed.
However, glycerol infusion had negligible effects on glucose production in both dogs and humans , whereas we have shown that direct infusion of FFA oleate can increase glucose production during low-dose insulin clamps in dogs In a number of studies, which were mostly conducted at basal insulin levels, Intralipid plus heparin increased gluconeogenesis but not glucose production, consistent with a compensatory reduction in glycogenolysis — This decrease in glycogenolysis may have been due, in part, to small changes in portal insulin concentrations induced by FFA stimulation of insulin secretion or to FFA-induced changes in plasma glucose However, a compensatory reduction in glycogenolysis was also found in studies in which basal insulin and glucose levels were clamped This is consistent with an intrahepatic autoregulatory mechanism, which has mainly been attributed to glucosephosphate stimulation of glycogen synthase and inhibition of phosphorylase Hepatic autoregulation may break down, as evidenced by the increase in basal glucose production induced by Intralipid plus heparin in other studies , The breakdown of autoregulation is facilitated under hyperinsulinemic clamp conditions , , , , , presumably because, at hyperinsulinemia, glycogenolysis is already maximally suppressed.
It is also possible that, as is the case in muscle, FFAs eventually impair insulin signaling, leading to an increase of both glycogenolysis and gluconeogenesis and perhaps also to a decrease of hepatic glucose uptake The latter is currently controversial , The effect of FFA on hepatic glucose production during hyperinsulinemic clamps, however, is more controversial than the effect of FFA on peripheral glucose uptake, as in some studies , , , Intralipid plus heparin failed to increase glucose production.
The negative results could be explained, in part, by the high rate of insulin infused, which completely suppressed glucose production, independent of FFA , , In addition, in most studies, plasma glucose-specific activity was not maintained constantly during the clamp, which leads to an underestimation of glucose production, particularly in the early non-steady-state periods of the clamp Due to this methodological problem, the time course of the effect of FFA on glucose production could not be accurately estimated in most studies , , although there is some suggestion that it might be more rapid than the time course of the effect of FFA on peripheral glucose uptake , , Some of the mechanisms that have been implicated in the FFA-induced impairment of hepatic glucose metabolism are shown in Table 1.
The classical Randle hypothesis has been expanded to include FFA-induced stimulation of gluconeogenesis. As is the case with FFA-induced inhibition of glycolysis, this pathway is also related to FFA oxidation.
Acetyl-CoA derived from FFA oxidation stimulates pyruvate carboxylase, and the increased NADH is necessary to produce glyceraldehydephosphate from 1,3 bisphosphoglycerate. Citrate-induced inhibition of PFK-1 which reduces glycolysis has been demonstrated in the perfused rat liver and in isolated hepatocytes exposed to FFA In the liver, in contrast to muscle, the increased content of glucosephosphate from reduction of glycolysis and stimulation of gluconeogenesis should not affect glucose uptake because liver glucokinase, unlike muscle hexokinase, is not inhibited by glucosephosphate.
However, translocation of glucokinase [ i. As is the case with muscle, FFA oxidation might be inadequate to fully account for the FFA-induced changes in glucose metabolism in liver. In addition, in the high-fat-fed rat, the resistance of glucose production to insulin was not ameliorated by inhibitors of FFA oxidation LCFA-CoAs accumulate in liver, when increased FFA exposure is combined with inhibition of fatty acid oxidation due to elevated malonyl-CoA Numerous allosteric effects of LCFA-CoA on purified hepatic enzyme preparations, including an inhibition of glucokinase , inhibition or stimulation of glucosephosphatase , inhibition of glycogen synthase , and stimulation of glycogen phosphorylase , have been described; however, the physiological importance of these effects in vivo is uncertain.
LCFA-CoAs stimulate PKC in hepatocytes Phosphorylation by PKC can directly influence enzyme activity [for example, PKC reduces hepatic glycogen synthase activity ] and impair hepatic insulin signaling. Accordingly, hepatic triglyceride content, which is proportional to cytosolic LCFA-CoA, seems to correlate with hepatic insulin resistance Our recent data show that in liver, FFAs increase glucose production in the basal state and induce hepatic insulin resistance.
The increase in basal glucose production is not progressive over time and is associated with increased hepatic citrate content Hepatic insulin resistance is progressive over time and is associated with a progressive increase in PKCδ membrane translocation Little is known about the role of the hexosamine pathway and of oxidative stress in the FFA-induced insulin resistance in the liver.
However, transgenic mice with selective overexpression of glutamine-fructose amidotransferase in the liver the rate-limiting enzyme for increasing flow through the hexosamine pathway show hepatic insulin resistance Furthermore, studies in collaboration with Dr.
Fantus suggest that the antioxidant NAC partially prevents FFA-induced hepatic insulin resistance in rats. In the liver as well as in muscle, FFAs induce enzymes of FFA oxidation, including CPT-1 , an effect mediated by PPARs In addition, in the liver, polyunsaturated fatty acids repress ACC gene expression by inhibiting SREBP-1 This could also contribute to the establishment of a chronic Randle cycle by decreasing malonyl-CoA, which inhibits CPT PPAR response elements have been shown on genes of enzymes that are not involved in the Randle cycle, such as phosphoenolpyruvate carboxykinase and glucokinase In addition, glucosephosphatase mRNA and protein are induced by Intralipid infusion in vivo , an effect that may be PPAR dependent Paradoxically, however, the predominant effect of PPAR activation is to increase rather than decrease hepatic insulin sensitivity, presumably by limiting fat accumulation.
In the liver, PPAR-independent effects account for the repression of glycolytic and lipogenic enzymes by n-3 and n-6 fatty acids the mechanism is through inhibition of SREBP-1 and by fatty acyl-CoA [the mechanism is through inhibition of hepatocyte nuclear factors ].
These effects may also improve hepatic glucose metabolism by limiting fat overload. In summary, increased provision of FFAs in a setting of increased energy availability leads to insulin resistance, thus preventing further intracellular accumulation of energy substrates.
It is unclear whether this response is entirely maladaptive or also provides some advantage in terms of avoidance of massive obesity and perhaps avoidance of cell toxicity from tissue fat overload, at least in cardiac muscle and liver The trade-off is a tendency to increased circulating energy substrates fat and glucose and compensatory hyperinsulinemia.
Hepatic insulin resistance and hyperinsulinemia in a setting of elevated FFA influx to the liver lead to increased production of VLDL particles reviewed in Ref. In insulin-resistant states, peripheral hyperinsulinemia is caused both by insulin hypersecretion and by reduced hepatic extraction of insulin One of the factors that may account for the impaired hepatic insulin extraction in obesity is elevated circulating FFA levels.
In the in situ -perfused rat liver, physiological FFA concentrations caused a decline in hepatic insulin extraction We have found that an elevation of circulating FFA from an Intralipid plus heparin infusion decreases hepatic insulin extraction in vivo in dogs In further studies, the impairment in hepatic insulin extraction appeared to be greater when equimolar oleate infusion was given portally vs.
peripherally to selectively elevate the hepatic FFA levels and thus mimic visceral obesity In agreement with our findings, Hennes et al. We have obtained similar findings in humans but only after prolonged Intralipid plus heparin infusion.
On the contrary, others failed to show changes in hepatic insulin extraction after 48 h of Intralipid plus heparin infusion performed during a h hyperglycemic clamp The majority of studies in humans did not show differences in peripheral insulin levels when hyperinsulinemic euglycemic clamps were carried out with or without Intralipid plus heparin infusion see, for example, Refs.
Because insulin was infused peripherally in these studies, however, the impact of the liver on the resultant peripheral insulin levels was less than with physiological portal insulin delivery. Furthermore, in most of these studies the duration of the Intralipid plus heparin infusion was not long.
In rats, the reduction in insulin clearance that we observed during a hyperinsulinemic clamp was greater after 7 h than 2 h of the Intralipid plus heparin infusion Hepatic insulin extraction depends on insulin binding to its receptor.
In isolated rat hepatocytes, low physiological concentrations of FFA reduced insulin binding and degradation in proportion to a decreased receptor number , In addition, FFAs may activate PKC Ref.
In our preliminary studies on isolated rat hepatocytes, PKC inhibition abolished the FFA-induced reduction in insulin binding We are currently determining the isoform of PKC involved. In vivo in rats, the progressive reduction of insulin clearance induced by Intralipid and heparin was associated with a progressive increase in PKCδ translocation , Interestingly, PKC activation has also been implicated in FFA-induced insulin resistance, which would explain the association between impaired insulin extraction and sensitivity The FFA-mediated reduction in hepatic insulin extraction may be viewed as an adaptive mechanism to generate peripheral hyperinsulinemia, and thus, to partially overcome the peripheral insulin resistance induced by FFAs.
This adaptive mechanism could relieve, in part, the stress on pancreatic β-cells imposed by insulin resistance Fatty acids are actively taken up and metabolized by β-cells and can regulate β-cell enzymes, ion channels, and genes , In the latter study , it was demonstrated that more saturated animal fat was far more potent in acutely facilitating insulin secretion in vivo and that the insulinotropic effects of individual fatty acids in a perfused rat pancreas model increased and decreased dramatically with chain length and degree of unsaturation, respectively.
Acute lowering of plasma FFAs with nicotinic acid results in a reduction in basal plasma insulin in both nonobese and obese healthy fasted individuals , and in patients with type 2 diabetes The prevailing FFA concentration also appears to play an important role in maintaining β-cell responsiveness to glucose during fasting The precise mechanisms responsible for the acute effects of FFAs on insulin secretion are still debated.
Intracellular FFAs are rapidly converted to fatty acyl-CoA, which can be oxidized to produce ATP. However, contrary to glucose, ATP generation followed by closure of the K-ATP channels is not the main mechanism of the acute stimulatory effect of FFAs on insulin secretion.
Instead, the key factor appears to be accumulation of cytosolic LCFA-CoA when FFA oxidation is inhibited by glucose-derived malonyl-CoA , , Of note, the acute effect of FFAs on insulin secretion does not appear to be specific for a glucose stimulus, which suggests that final common events in stimulus secretion coupling may be involved Some of these mechanisms PKC activation may be operational in both β-cells and peripheral tissues and thus link insulin resistance and hyperinsulinemia at the cellular level.
Another of these mechanisms may be increased hexosamine flux. Recent findings in transgenic mice with selective overexpression of glutamine-fructose amidotransferase in the β-cell suggest that increased hexosamine flux may lead to insulin hypersecretion with secondary insulin resistance Several in vitro studies in β-cell lines and in rodent and human islets have subsequently confirmed that insulin secretion at high glucose concentrations is impaired in a time-dependent fashion by exposure to FFAs — Islets from prediabetic Zucker diabetic fatty ZDF rats and from fructose-fed insulin-resistant rats appear to be more susceptible to this FFA-mediated desensitization of GSIS , Under the same conditions, however, basal insulin secretion at low glucose concentrations was elevated in normal rodent islets and islet cell lines in most studies , , , — , , but not in human islets Furthermore, insulin secretion at low glucose concentration is either unchanged or decreased by FFAs in islets from ZDF prediabetic rats or prediabetic Otsuka Long-Evans Tokushima fatty rats , This term has been applied to describe FFA-induced functional impairments in GSIS as well as reduction in β-cell mass.
The functional effect of chronically elevated FFAs on insulin secretion, in contrast to the acute enhancing effect, appears to be specific for glucose in vitro and in vivo , and at least part of the effect requires FFA oxidation , , Prolonged exposure to FFAs may also lead to decreased GLUT2 and glucokinase expression, thereby decreasing the glucose-sensing capacity of the β-cell , Other studies, however, have shown that prolonged exposure to FFAs does not decrease and may even increase glucose utilization and ATP generation, and reduces glucose oxidation only slightly in β-cells , , , casting doubts on FFA-mediated impairment of glucose metabolism as an important mechanism for the β-cell lipotoxic effect.
In addition, FFAs decrease insulin biosynthesis , , , , , alter proinsulin processing , and decrease insulin gene transcription , by unclear mechanisms.
Furthermore, reduced β-cell mass may be caused by FFA-induced stimulation of apoptosis, which has been repeatedly demonstrated in in vitro studies and has been linked to FFA-mediated induction of iNOS, increase in ceramide synthesis, and perhaps oxidative stress , — Some of the biochemical mechanisms of β-cell lipotoxicity have also been implicated in the FFA-induced impairment in insulin action Table 1 and may be common to glucotoxicity as well.
Most of these lipotoxic mechanisms appear to be linked to fatty acid esterification rather than oxidation. For example, palmitate-induced reduction of rat islet insulin mRNA levels was shown to depend on induction of fatty acid esterification pathway at high glucose levels , These intracellular triglycerides can be hydrolyzed by HSL, which is expressed and active in β-cells and, therefore, may constitute an in situ reservoir of long-chain fatty acids.
Furthermore, depletion of intracellular triglycerides in ZDF rat islets by activating intracellular FFA oxidation using leptin receptor overexpression with leptin treatment or troglitazone treatment restores the FFA-induced defects in cellular ultrastructure, mitochondrial integrity, glucose sensing, insulin biosynthesis, and GSIS , UCP-2 has been implicated in the functional secretory defect chronically induced by FFAs and can decrease insulin secretion by decreasing ATP production from glucose Paradoxically, however, adenovirus-mediated transfer of UCP-2 in pancreatic β-cells from Zucker diabetic rats has been shown to increase fatty acid oxidation and improve insulin secretion The question of whether chronically elevated plasma FFAs actually impair GSIS in vivo , particularly in humans, remains controversial, with some groups showing an impairing effect of FFAs, whereas others claim that chronically elevated FFAs actually facilitate insulin secretion.
As we will discuss, it is possible to explain the apparently discrepant findings from the various studies that have been reported in humans. In vivo insulin secretion needs to be interpreted in relation to concurrent changes in insulin sensitivity and perhaps also insulin clearance.
There is a well-described hyperbolic relationship between insulin secretion and insulin sensitivity S I , implying that the product of insulin secretion and S I is a constant [called the disposition index DI ; Ref.
In situations, such as in type 2 diabetes, in which β-cell function is defective and cannot fully compensate for the decline in S I , there is a decline in DI but not necessarily in absolute insulin secretion. Because elevation of plasma FFAs results in a reduction in S I , , , it is critical to take this effect into account in interpreting any FFA-mediated change in insulin secretion.
The FFA effect on insulin clearance should also be taken into account, as this is expected to decrease, in part, the need for insulin secretion. Finally, when examining the in vivo data on the action of prolonged elevation of plasma FFAs, one has to keep in mind that iv infusion of triglyceride emulsion could also modulate autonomic nervous system activity, which can in turn affect both insulin sensitivity and insulin secretion The paper of Boden et al.
These investigators found higher absolute insulin secretion during a h hyperglycemic clamp with concurrent iv infusion of Intralipid plus heparin.
They did not, however, examine insulin secretion in relationship to the FFA-mediated change in S I , which was reduced with infusion of Intralipid plus heparin in this study. In contrast to the above findings, Paolisso et al.
The impairment in GSIS was reversible, implicating a functional defect. Our group assessed insulin secretion in lean, healthy men after an iv infusion of Intralipid and heparin resulting in a 2-fold elevation of fasting plasma FFAs.
We found that acute elevation of FFAs for 1. In contrast, the FFA-mediated potentiating effect on GSIS was completely lost after 48 h of elevation of plasma FFA, and there was a concomitant significant decrease in insulin sensitivity, and consequently, a significantly lower DI.
We also found that obese nondiabetic subjects had an absolute reduction of insulin secretion after prolonged elevation of plasma FFA, whereas diabetic subjects displayed a slight but significant absolute increase in insulin secretion These findings suggest that individuals at risk for developing type 2 diabetes may be more susceptible to FFA-mediated β-cell desensitization than healthy insulin-sensitive individuals, but that those who already have type 2 diabetes may have no further FFA-induced deterioration in β-cell function.
Our findings in humans are supported by similar findings in rats In addition, our studies in rats suggest that the type of fatty acid is an important determinant of the effect of prolonged plasma FFA on GSIS. In our studies, all types of fat appeared to disable the β-cell-compensatory response to FFA-induced insulin resistance the latter is less in rats than in humans, probably accounting for the findings of a small absolute reduction of GSIS by Intralipid in rats but not in humans , perhaps to a different extent Furthermore, our studies suggest that prediabetic rat models of type 2 diabetes , and perhaps also type 1 diabetes , may be particularly susceptible to the fat-induced impairment of GSIS.
As to the mechanism of this effect, our preliminary experiments in collaboration with Dr. In contrast to the impairing effect of a prolonged elevation of FFAs on GSIS, we recently failed to demonstrate a similar effect on arginine-stimulated insulin secretion These findings are in keeping with in vitro studies that have suggested that the impairment of β-cell insulin secretion mediated by prolonged exposure to FFAs may be specific for GSIS , , , Because arginine is believed to stimulate insulin secretion distal in the insulin secretion cascade of events, primarily by inducing depolarization of the β-cell membrane , , the absence of a significant effect, combined with our previous observation of a FFA-induced reduction of GSIS, would suggest that prolonged FFA exposure may alter GSIS primarily by interfering with the metabolism of glucose, leaving relatively intact the exocytotic machinery.
From the above discussion, the following conclusions can be drawn: 1 The effects of fatty acids on β-cells are complex and probably involve multiple direct metabolic interactions as well as delayed modulation of gene expression, resulting in time-dependent differential effects on insulin secretion in vitro.
Furthermore, based on our results in humans, it is possible that individuals at risk for developing type 2 diabetes may be more susceptible to the β-cell lipotoxic effect of fatty acids.
FFAs, therefore, appear to be an important link between obesity, insulin resistance, fat intolerance, and the development of β-cell dysfunction and type 2 diabetes. The challenge for investigators is to better define the molecular basis for the β-cell lipotoxic or glucolipotoxic effect, and to further delineate the metabolic phenotypes and genetic factors that interact with fatty acids in vivo , placing individuals at risk of developing β-cell dysfunction.
Theoretically, a sustained reduction in FFA flux from adipose tissue would be predicted to result in improvement in the metabolic abnormalities discussed throughout this review. Therapies that directly or indirectly improve insulin sensitivity, such as weight reduction, exercise, oral hypoglycemic agents, and insulin, are indeed associated with a reduction in FFAs and improvement in many of the metabolic disturbances of IRS and type 2 diabetes.
It has not, however, been possible to prove the link between FFA reduction and improvement in these other parameters in response to such therapies, due to the multiple metabolic effects of such therapies.
Drugs that target adipose tissue lipolysis per se have been associated with only partial and inconsistent clinical success, as discussed below, partly due to their inability to produce a sustained reduction in plasma FFAs over a prolonged period of time. The agent that has been used most frequently to investigate the metabolic and clinical effects of reducing fatty acids is the antilipolytic, long-acting nicotinic acid analog, acipimox , Acute administration of acipimox has been shown by numerous investigators to reduce plasma FFAs, fatty acid oxidation, and gluconeogenesis and to increase glucose oxidation rates, with some but not all studies showing suppression of endogenous glucose production, increased insulin-mediated suppression of glucose production, and insulin-mediated glucose uptake — In addition, large VLDL particle VLDL1 production has been shown to be reduced , as LDL particle size shifted from the smaller, dense particles to larger particles, a change that may be associated with less atherogenicity , and insulin secretion was potentiated with 1-wk acipimox treatment There is a rebound elevation of FFAs that occurs with longer-term acipimox treatment, which may limit its potential therapeutic benefit , , , Diabetic patients treated with acipimox have shown variable but generally disappointing clinical improvement in glycemic control , — , whereas the triglyceride-lowering and high density lipoprotein-raising effects of acipimox in hyperlipidemic patients have been more impressive — Acipimox has also been used with some success to reduce LDL in patients with hypercholesterolemia and combined hyperlipidemia — We speculate that drugs whose principal mechanism of action is to inhibit adipose tissue lipolysis are unlikely to prove totally effective in ameliorating the metabolic disturbances associated with IRS and type 2 diabetes.
Firstly, they are destined to produce a rebound increase in adipocyte triglyceride lipolysis due to the mass effect of greater adipocyte triglyceride stores that occurs secondary to the drug-induced inhibition of lipolysis. Secondly, they fail to correct the fundamental defect of insulin-mediated fatty acid re-esterification in adipose tissue and are therefore unlikely to effectively reduce the postprandial diversion of FFAs from adipose tissue to other tissues of the body.
On the other hand, agents such as PPARγ activators that overcome insulin resistance of adipose tissue by improving adipocyte FFA esterification are postulated to more effectively reduce the deleterious metabolic effects of fat dysregulation.
Possibly the only truly effective therapies will be those designed to reduce positive net energy balance. At present, however, the most important of these therapies are lifestyle changes.
Dysregulation of fat metabolism occurs very early in the development of insulin resistance and well before the onset of hyperglycemia in type 2 diabetes. The mechanism for this dysregulation remains to be determined; however, there are suggestions that it might be related to decreased oxidative or fat oxidative capacity , with a tendency toward a positive energy balance and tissue triglyceride accumulation.
There is general agreement that elevated FFA flux from an expanded adipose tissue to nonadipose tissues has a deleterious effect on insulin regulation of carbohydrate metabolism, is an important cause of the hypertriglyceridemia of IRS and type 2 diabetes, aggravates cytosolic triglyceride accumulation in nonadipose tissues, and may have other direct adverse effects, such as effects on endothelium, myocardium, and cell proliferation.
More controversial is the role of chronic elevation of FFAs on pancreatic β-cell function and the role of fatty acids in the conversion of compensated insulin resistance to type 2 diabetes, but the bulk of evidence suggests that they may play a role.
There is little question that abnormal fatty acid metabolism is an important component of IRS and type 2 diabetes. A major question that remains to be answered is precisely how important a role fatty acids play in the cross-talk between adipose tissue and extraadipocyte insulin-sensitive and insulin-secretory tissues.
Are fatty acids the dominant signal between these tissues, or will other factors such as peptides and cytokines prove to play a more important role? We would like to thank Dr. Katherine Cianflone for her critical review of this manuscript. We would also like to thank our numerous colleagues and collaborators, with whom we have had stimulating discussions regarding the concepts proposed in this review, and whose ideas we have attempted to integrate into the above discussion.
is a Canada Research Chair in Diabetes and Career Investigator of the Heart and Stroke Foundation of Canada. has been supported by a Research Fellowship jointly funded by the Canadian Institutes of Health Research CIHR and the Heart and Stroke Foundation of Canada and is now a New Investigator of the CIHR.
Steppan CM , Bailey ST , Bhat S , Brown EJ , Banerjee RR , Wright CM , Patel HR , Ahima RS , Lazar MA The hormone resistin links obesity to diabetes. Nature : — Google Scholar. Kahn BB , Flier JS Obesity and insulin resistance.
J Clin Invest : — Reaven GM Diet and Syndrome X. Curr Atheroscler Rep 2 : — Baldeweg SE , Golay A , Natali A , Balkau B , Del Prato S , Coppack SW Insulin resistance, lipid and fatty acid concentrations in healthy Europeans.
Eur J Clin Invest 30 : 45 — Laws A , Hoen HM , Selby JV , Saad MF , Haffner SM , Howard BV Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status.
Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study IRAS Investigators. Arterioscler Thromb Vasc Biol 17 : 64 — Coppack SW , Evans RD , Fisher RM , Frayn KN , Gibbons GF , Humphreys SM , Kirk ML , Potts JL , Hockaday TD Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal.
Metabolism 41 : — J Clin Endocrinol Metab 72 : — Reaven GM , Hollenbeck C , Jeng CY , Wu MS , Chen YD Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37 : — Knowler WC , Pettitt DJ , Saad MF , Bennett PH Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis.
Diabetes Metab Rev 6 : 1 — Paolisso G , Tataranni PA , Foley JE , Bogardus C , Howard BV , Ravussin E A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM.
Diabetologia 38 : — Charles MA , Eschwege E , Thibult N , Claude JR , Warnet JM , Rosselin GE , Girard J , Balkau B The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study.
Diabetologia 40 : — Axelsen M , Smith U , Eriksson JW , Taskinen MR , Jansson PA Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes.
Ann Intern Med : 27 — Eriksson JW , Smith U , Waagstein F , Wysocki M , Jansson PA Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?
Diabetes 48 : — Perseghin G , Scifo P , De Cobelli F , Pagliato E , Battezzati A , Arcelloni C , Vanzulli A , Testolin G , Pozza G , Del Maschio A , Luzi L Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H—13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents.
Perseghin G , Ghosh S , Gerow K , Shulman GI Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46 : — Arner P , Bolinder J , Engfeldt P , Ostman J The antilipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia, and starvation.
Metabolism 30 : — Bolinder J , Lithell H , Skarfors E , Arner P Effects of obesity, hyperinsulinemia, and glucose intolerance on insulin action in adipose tissue of sixty-year-old men. Diabetes 35 : — Large V , Arner P Regulation of lipolysis in humans.
Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab 24 : — Arner P , Bolinder J , Engfeldt P , Hellmer J , Ostman J Influence of obesity on the antilipolytic effect of insulin in isolated human fat cells obtained before and after glucose ingestion.
J Clin Invest 73 : — Campbell PJ , Carlson MG , Nurjhan N Fat metabolism in human obesity. Am J Physiol : E — E Jensen MD , Haymond MW , Rizza RA , Cryer PE , Miles JM Influence of body fat distribution on free fatty acid metabolism in obesity.
J Clin Invest 83 : — Groop LC , Bonadonna RC , DelPrato S , Ratheiser K , Zyck K , Ferrannini E , DeFronzo RA Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus.
Evidence for multiple sites of insulin resistance. J Clin Invest 84 : — Horowitz JF , Coppack SW , Paramore D , Cryer PE , Zhao G , Klein S Effect of short-term fasting on lipid kinetics in lean and obese women.
Del Prato S , Enzi G , Vigili de Kreutzenberg S , Lisato G , Riccio A , Maifreni L , Iori E , Zurlo F , Sergi G , Tiengo A Insulin regulation of glucose and lipid metabolism in massive obesity.
Diabetologia 33 : — Groop LC , Saloranta C , Shank M , Bonadonna RC , Ferrannini E , DeFronzo RA The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin- dependent diabetes mellitus.
J Clin Endocrinol Metab 72 : 96 — Jansson PA , Larsson A , Smith U , Lonnroth P Glycerol production in subcutaneous adipose tissue in lean and obese humans. J Clin Invest 89 : — Bolinder J , Kerckhoffs DA , Moberg E , Hagstrom-Toft E , Arner P Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects.
Diabetes 49 : — Groop LC , Bonadonna RC , Simonson DC , Petrides AS , Shank M , DeFronzo RA Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity.
Am J Physiol : E79 — E Abbasi F , McLaughlin T , Lamendola C , Reaven GM Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance.
Metabolism 49 : — Groop LC , Bonadonna RC , DelPrato S , Ratheiser K , Zyck K , Ferrannini, E , DeFronzo RA Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Robinson C , Tamborlane WV , Maggs DG , Enoksson S , Sherwin RS , Silver, D , Shulman GI , Caprio S Effect of insulin on glycerol production in obese adolescents.
Bjorntorp P , Bergman H , Varnauskas E Plasma free fatty acid turnover rate in obesity. Acta Med Scand : — Gulli G , Ferrannini E , Stern M , Haffner S , DeFronzo RA The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents.
Diabetes 41 : — Gelding SV , Coldham N , Niththyananthan R , Anyaoku V , Johnston DG Insulin resistance with respect to lipolysis in non-diabetic relatives of European patients with type 2 diabetes.
Diabet Med 12 : 66 — Van Harmelen V , Reynisdottir S , Cianflone K , Degerman E , Hoffstedt J , Nilsell K , Sniderman A , Arner P Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin.
J Biol Chem : — Riemens SC , Sluiter WJ , Dullaart RP Enhanced escape of non-esterified fatty acids from tissue uptake: its role in impaired insulin-induced lowering of total rate of appearance in obesity and type II diabetes mellitus.
Diabetologia 43 : — Wolfe RR , Peters EJ Lipolytic response to glucose infusion in human subjects. Coppack SW , Frayn KN , Humphreys SM , Dhar H , Hockaday TD Effects of insulin on human adipose tissue metabolism in vivo.
Clin Sci Colch 77 : — Campbell PJ , Carlson MG , Hill JO , Nurjhan N Regulation of free fatty acid metabolism by insulin in humans: role of lipolysis and reesterification. Frayn KN , Shadid S , Hamlani R , Humphreys SM , Clark ML , Fielding BA , Boland O , Coppack SW Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition.
Frayn KN , Humphreys SM , Coppack SW Net carbon flux across subcutaneous adipose tissue after a standard meal in normal-weight and insulin-resistant obese subjects.
Int J Obes Rel Metab Disord 20 : — Evans K , Clark ML , Frayn KN Effects of an oral and intravenous fat load on adipose tissue and forearm lipid metabolism. Diabetologia 34 : — Farese Jr RV , Cases S , Smith SJ Triglyceride synthesis: insights from the cloning of diacylglycerol acyltransferase.
Curr Opin Lipidol 11 : — Roncari DA , Mack EY , Yip DK Enhancement of microsomal phosphatidate phosphohydrolase and diacylglycerol acyltransferase activity by insulin during growth of rat adipocyte precursors in culture. Can J Biochem 57 : — Fielding BA , Frayn KN Lipoprotein lipase and the disposition of dietary fatty acids.
Br J Nutr 80 : — Metabolism 40 : — Metabolism 44 : — Sadur CN , Yost TJ , Eckel RH Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity.
J Clin Endocrinol Metab 59 : — Kim JK , Fillmore JJ , Chen Y , Yu C , Moore IK , Pypaert M , Lutz EP , Kako Y , Velez-Carrasco W , Goldberg IJ , Breslow JL , Shulman GI Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance.
Proc Natl Acad Sci USA 98 : — Hamilton JA , Kamp F How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids?
Storch J , Thumser AE The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta : 28 — Coburn CT , Hajri T , Ibrahimi A , Abumrad NA Role of CD36 in membrane transport and utilization of long-chain fatty acids by different tissues.
J Mol Neurosci 16 : — Baillie AGS , Coburn CT , Abumrad NA Reversible binding of long-chain fatty acids to purified FAT, the adipose CD36 homolog. J Membr Biol : 75 — Aitman TJ , Glazier AM , Wallace CA , Cooper LD , Norsworthy PJ , Wahid FN , Al Majali KM , Trembling PM , Mann CJ , Shoulders CC , Graf D , St Lezin E , Kurtz TW , Kren V , Pravenec M , Ibrahimi A , Abumrad NA , Stanton LW , Scott J Identification of Cd36 Fat as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats.
Nat Genet 21 : 76 — Aitman TJ CD36, insulin resistance, and coronary heart disease. Lancet : — Coburn CT , Knapp Jr FF , Febbraio M , Beets AL , Silverstein RL , Abumrad NA Defective uptake and utilization of long-chain fatty acids in muscle and adipose tissues of CD36 knockout mice.
Hajri T , Ibrahimi A , Coburn CT , Knapp FF , Kurtz T , Pravenec M , Abumrad NA Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia and myocardial hypertrophy. Pravenec M , Landa V , Zidek V , Musilova A , Kren V , Kazdova L , Aitman TJ , Glazier AM , Ibrahimi A , Abumrad NA , Qi N , Wang JM , St Lezin EM , Kurtz TW Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats.
Nat Genet 27 : — Febbraio M , Abumrad NA , Hajjar DP , Sharma K , Cheng W , Pearce SF , Silverstein RL A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism.
Miyaoka K , Kuwasako T , Hirano K , Nozaki S , Yamashita S , Matsuzawa Y CD36 deficiency associated with insulin resistance. Nozaki S , Tanaka T , Yamashita S , Sohmiya K , Yoshizumi T , Okamoto F , Kitaura Y , Kotake C , Nishida H , Nakata A , Nakagawa T , Matsumoto K , Kameda-Takemura K , Tadokoro S , Kurata Y , Tomiyama Y , Kawamura K , Matsuzawa Y CD36 mediates long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency.
Mol Cell Biochem : — Berk PD , Zhou S , Kiang C , Stump DD , Fan X , Bradbury MW Selective up-regulation of fatty acid uptake by adipocytes characterizes both genetic and diet-induced obesity in rodents.
Binnert C , Koistinen HA , Martin G , Andreelli F , Ebeling P , Koivisto VA , Laville M , Auwerx J , Vidal H Fatty acid transport protein-1 mRNA expression in skeletal muscle and in adipose tissue in humans. Am J Physiol Endocrinol Metab : E — E Murray I , Sniderman AD , Havel PJ , Cianflone K Acylation stimulating protein ASP deficiency alters postprandial and adipose tissue metabolism in male mice.
Wetsel RA , Kildsgaard J , Zsigmond E , Liao W , Chan L Genetic deficiency of acylation stimulating protein ASP C3ades-Arg does not cause hyperapobetalipoproteinemia in mice.
Maslowska M , Vu H , Phelis S , Sniderman AD , Rhode BM , Blank D , Cianflone K Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest 29 : — Walsh MJ , Sniderman AD , Cianflone K , Vu H , Rodriguez MA , Forse RA The effect of ASP on the adipocyte of the morbidly obese.
J Surg Res 46 : — BMJ : — Frayn KN Visceral fat and insulin resistance-causative or correlative? Br J Nutr 83 Suppl 1 :S71—S Misra A , Garg A , Abate N , Peshock RM , Stray-Gundersen J , Grundy SM Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men.
Obes Res 5 : 93 — Abate N , Garg A , Peshock RM , Stray-Gundersen J , Adams-Huet B , Grundy SM Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM.
Diabetes 45 : — Ross R , Leger L , Morris D , de Guise J , Guardo R Quantification of adipose tissue by MRI: relationship with anthropometric variables.
J Appl Physiol 72 : — Ross R , Shaw KD , Martel Y , de Guise J , Avruch L Adipose tissue distribution measured by magnetic resonance imaging in obese women. Am J Clin Nutr 57 : — Campra JL , Reynolds TB The hepatic circulation.
In: Arias IM , Popper H , Schachter D , Shafritz DA , eds. The liver: biology and pathobiology. New York : Raven Press ; — Parker DR , Carlisle K , Cowan FJ , Corrall RJ , Read AE Postprandial mesenteric blood flow in humans: relationship to endogenous gastrointestinal hormone secretion and energy content of food.
Rather, different cell type carry out different processes at different times. To learn more, visit Metabolic pathways. Amino acids are used for building proteins through a process called translation. For a refresher on how cells build proteins, visit Transcribe and Translate a Gene.
While it may seem like the fat that pads our bodies sits there, stubbornly refusing to budge, fat is a very active tissue that is constantly turning over its inventory. After a meal, fat is put into storage. Between meals, stored fat is slowly released, keeping our cells supplied with fuel.
While the brain needs glucose, our liver, muscle, and fat cells prefer to burn fat. When calorie consumption is in balance, we maintain a healthy supply of fat that's available when we need it.
This extra energy reserve helps us survive longer periods of fastinglike when food is scarce or when we don't have a chance to eat. Fat stores are especially important during illness: they nourish our cells and provide the immune system with energy to fight off infections when we're too sick to eat.
However, when we routinely eat more calories than we need, our bodies get out of balance. Fat stores can build up, leading to obesity and related health problems. Fat tissue does more than just store energy. To learn about some of the more active roles of fat, visit The Friendly Side of Fat.
The protein in our food supplies amino acids that we need for replacing proteins lost in urine, in shed hair and skin, and through other means.
Because we can't store protein for the long-term, we need to eat some every day especially the 9 "indispensible" or essential amino acids that our cells cannot make from other nutrients. The amount of protein we need to eat to replace what we lose is relatively modest.
Any protein we eat beyond what we need for rebuilding is burned for energy, converted to sugar, or most commonly converted to fat. While some of the protein from our food becomes protein in our bodies, eating a high-protein diet will not necessarily help the body build more muscle protein.
Mostly it just builds fat. A number of diets recommend eating high amounts of protein, and some evidence suggests that for people trying to lose weight a high-protein diet reduces hunger and food cravings. But regardless of what we eat, weight loss will only occur when we burn more calories than we consume.
When a high-protein diet contains more calories than we need, the excess still builds up as fat. Sugars consumed in excess are also readily converted to fat for storage. To learn more, visit Spotlight on Sugar. The protein from our food doesn't necessarily become protein in our bodies.
Our cells can burn amino acids as fuel and convert them into sugar and fat. Because food has not always been readily available, humans and other animals have evolved ways to store fuel reserves in their bodies.
When food is plentiful, the body packs away extra calories in fat reserves. The stored fat fuels the body when food is scarce. But why does the body go through the trouble of converting amino acids and sugars to fat for storage? Wouldn't it make more sense to store more proteins and glycogen?
It turns out that fat is a much more efficient way to store energy. Fat has about 9 calories per gram, and protein and carbohydrate have just 4. In living tissue, this difference is even greater.
Gary Stlrage. The primary xnd, environmental, Metabilism metabolic factors responsible Metabo,ism causing insulin resistance and pancreatic β-cell failure and the Metabolism and fat storage sequence Metaboliwm events leading to Metabolism and fat storage development of type 2 diabetes Exercise and Nutrition Tips not Mettabolism fully understood. Ztorage of triglyceride storage andd lipolysis in insulin-sensitive tissues are an early manifestation Metabolism and fat storage conditions characterized Coenzyme Q levels insulin resistance and are detectable before the Resupply tracking solutions of postprandial or fasting hyperglycemia. Increased free fatty acid FFA flux from adipose tissue to nonadipose tissue, resulting from abnormalities of fat metabolism, participates in and amplifies many of the fundamental metabolic derangements that are characteristic of the insulin resistance syndrome and type 2 diabetes. It is also likely to play an important role in the progression from normal glucose tolerance to fasting hyperglycemia and conversion to frank type 2 diabetes in insulin resistant individuals. Adverse metabolic consequences of increased FFA flux, to be discussed in this review, are extremely wide ranging and include, but are not limited to: 1 dyslipidemia and hepatic steatosis, 2 impaired glucose metabolism and insulin sensitivity in muscle and liver, 3 diminished insulin clearance, aggravating peripheral tissue hyperinsulinemia, and 4 impaired pancreatic β-cell function. The precise biochemical mechanisms whereby fatty acids and cytosolic triglycerides exert their effects remain poorly understood.Energy metabolism and nutrition storqge hand in hand. Coenzyme Q levels our diet fta get our Metsbolism carbohydrates, fats and proteins. Inside our bodies these molecules get broken Metaboliism into smaller storagw, Resupply tracking solutions, stored especially after a mealreleased from these stores between meals or during a fast and further metabolized.
Scroll through the qnd on this page to learn Young athletes development what happens to fat, why our body requires it, and what our body Macronutrients for body recomposition with Metagolism.
The relative contributions of stkrage and Automated glucose monitoring acids to energy fa in the body change over Metaholism hour period ans meal intake: fatty storge contribute to overnight Metabooism Coenzyme Q levels during Mftabolism day or with food ingestion, Coenzyme Q levels.
The animations below should Metabolism and fat storage vat in Annd order in anv they appear for storagr understanding. Please storge the Mteabolism at the bottom storae this page for definition of relevant sotrage terms. Metabolism and fat storage major Metbaolism Resupply tracking solutions of the body is stogage or TAG in adipose Coenzyme Q levels. Merabolism in liver Metqbolism muscle is more of a short-term store of carbohydrates.
From the above animations, we can see how these molecules play an interconnected role to provide energy or be stored at different times. But during metabolic diseases like diabetes or obesity these processes do not occur optimally. An example is formation of triglycerides from fatty acids and glycerol.
FATTY ACIDS: are building blocks of lipid molecules such as fats. They can be obtained both through diet or breakdown of stored fats in the body. They are insoluble in water and therefore transported in complex particles called lipoproteins.
The excess fatty acids and cholesterol in the liver are converted to their respective esters and packaged with proteins into VLDL. Keith N. Metabolic Regulation: A Human Perspective.
Hoboken: John Wiley and Sons, Inc. Denise R. Lippincott Illustrated Reviews: Biochemistry. Philadelphia: Wolters Kluwer. Liangyou Rui. Energy Metabolism in the Liver. Compr Physiol. Glatz and Luiken. Time for a détente in the war on the mechanism of cellular fatty acid uptake.
Journal of Lipid Research. This lesson was designed by Shraddha Nayak, a postdoctoral fellow in the Animation Lab at the University of Utah with guidance from lab members and its head, Janet Iwasa. It was created in collaboration with biochemists and educators, Janet Lindsley and Amy Hawkins from the University of Utah, and Judith Simcox from the University of Wisconsin-Madison.
We thank the Diabetes and Metabolism Research Center DMRC at the University of Utah and its donors for funding this project. This work falls under a Creative Commons Attribution-NonCommercial-ShareAlike 4. Home current Fat Metabolism Animations Glossary Creators Contact.
How does the body release and store fat? Click here to download. Click here to download The major fuel store of the body is triglyceride or TAG in adipose tissue. Glossary click to open and close. References click to open and close. CREATORS This lesson was designed by Shraddha Nayak, a postdoctoral fellow in the Animation Lab at the University of Utah with guidance from lab members and its head, Janet Iwasa.
TERMS OF USE This work falls under a Creative Commons Attribution-NonCommercial-ShareAlike 4.
: Metabolism and fat storage| Background | Metabolism and fat storage problem Meabolism that most of storaage studies Boost Your Metabolic Rate smokers and individuals Coenzyme Q levels Metwbolism, but Resupply tracking solutions, chronic and fatal diseases. Lancet : — We will also critically examine the Gluten-Free Options for a role of abnormal fatty acid metabolism in skeletal muscle and intestinal absorption of fatty acids in IRS. El-Shamy 1 Bulletin of the National Research Centre volume 43Article number: Cite this article k Accesses 4 Citations 73 Altmetric Metrics details. In a number of studies, which were mostly conducted at basal insulin levels, Intralipid plus heparin increased gluconeogenesis but not glucose production, consistent with a compensatory reduction in glycogenolysis — PMID |
| How does the body release and store fat? | In living tissue, Resupply tracking solutions fxt is even Coenzyme Q levels. Fielding BAPlant-based muscle building KN Lipoprotein Metabolism and fat storage Meabolism the disposition of dietary Metabolis acids. In ad, transgenic mice with inactivation of PKCθ have recently been shown to be protected from lipid-induced defects in insulin action and signaling in skeletal musclesuggesting a direct role of PKCθ in the development of fat-induced insulin resistance in skeletal muscle. Why Fat? J Clin Pharm Ther — Article CAS PubMed Google Scholar Whingham LD, Watras CA, Scholler DA Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. |
| Physiological process of fat loss | Bulletin of the National Research Centre | Full Text | Proc Nebr Acad Sci Affil Soc 85th Annu Meet, p Dolnik V, Blyumental TI Autumnal premigratory and migratory periods in the chaffinch Fringilla coelebs coelebs and some other temperate-zone birds. Condor — Donaldson WE Regulation of fatty acid synthesis. Eckel RH Adipose tissue lipoprotein lipase. In: Borensztajn J ed Lipoprotein lipase. Evener, Chicago, pp 79— Evans PR Winter fat deposition and overnight survival of yellow buntings Emberiza citrinella L. J Anim Ecol — Farner DS, Oksche A, Kamemoto FI, King JR, Cheyney HE A comparison of the effect of long daily photoperiods on the pattern of energy storage in migratory and nonmigratory finches. Filippo G de, Milone M, Esposito R, Caliendo MF Winter and premigratory lipid metabolism in Erithacus r. Abstract from 14th Conference of European Comparative Endocrinologists, University of Salzberg, Austria, September 4—9. Florant G, Greenwood MRC Seasonal variations in pancreatic function in marmots: the role of pancreatic hormones and lipoprotein lipase in fat deposition. In: Heller HC, Musacchia XJ, Wang LCH eds Living in the cold: physiological and biochemical adaptations. Elsevier Science, New York, pp — Fried SK, Hill JO, Nickel M, DiGirolamo M Prolonged effects of fasting-refeeding on rat adipose tissue lipoprotein lipase activity: influence of caloric restriction during refeeding. J Nutr — Fry CH, Ash JKS, Ferguson-Lees IJ Spring weights of some Palaearctic migrants at Lake Chad. Ibis — Fry CH, Ferguson-Lees IF, Dowsett RJ Flight muscle hypertrophy and ecophysiological variation of yellow wagtail Motacilla flava races at Lake Chad. J Zool Lond — Garfinkel AS, Baker N, Schotz MC Relationship of lipoprotein lipase activity to triglyceride uptake in adipose tissue. J Lipid Res — Garrett RL, Young RJ Effect of micelle formation on the absorption of neutral fat and fatty acids by the chicken. George JC, Vallyathan NV Lipase and succinic dehydrogenase activity of the particulate fractions of the breast muscle homogenate of the migratory starling Sturnus roseus in the pre-migratory and post-migratory periods. J Cell Comp Physiol — CrossRef CAS Google Scholar. Gibson WR, Nalbandov AV Lipolysis and lipogenesis in liver and adipose tissue of hypo-physectomized cockerels. Am J Physiol 6 : — Gifford CE, Odum EP Bioenergetics of lipid deposition in the bobolink, a transequatorial migrant. Goodridge AG Regulation of the activity of acetyl coenzyme A carboxylase by palmitoyl coenzyme A and citrate. J Biol Chem — Goodridge AG Hormonal regulation of the activity of the fatty acid synthesizing system and of the malic enzyme concentration in liver cells. Goodridge AG Fatty acid synthesis in eucaryotes. In: Vance DE, Vance JE eds Biochemistry of lipids and membranes. Goodridge AG, Ball EG Studies on the metabolism of adipose tissue XVIII. In vitro effects of insulin, epinephrine, and glucagon on lipolysis and glycolysis in pigeon adipose tissue. Goodridge AG, Ball EG Lipogenesis in the pigeon: in vitro studies. Am J Physiol — Goodridge AG, Ball EG The effect of prolactin on lipogenesis in the pigeon: in vitro studies. Biochemistry — Goodridge AG, Crish JF, Hillgartner FB, Wilson SB Nutritional and hormonal regulation of the gene for avian malic enzyme. Gornall DA, Kuksis A, Morley N Lipid-metabolizing enzymes in the ovary of the laying hen. Biochim Biophys Acta — Grande F Effect of glucagon on plasma free fatty acids and blood sugar in birds. Grande F Effect of catecholamines on plasma free fatty acids and blood sugar in birds. Grande F, Prigge WF Glucagon infusion, plasma FFA and triglycerides, blood sugar and liver lipids in birds. Gray JM, Yarian D, Ramenofsky M Corticosterone, foraging behavior, and metabolism in dark-eyed juncos Junco hyemalis. Gen Comp Endocrinol, in press. Metabolism — Gwinner E, Biebach H, Kries I Food availability affects migratory restlessness in caged garden warblers Sylvia borin. Naturwissenschaften Hamosh M, Hamosh P Lipoprotein lipase: its physiological and clinical significance. Mol Aspects Med — Hazelwood RL Endocrine control of avian carbohydrate metabolism. Poult Sci — Heald PJ, McLaughlan PM, Rookledge KA The effects of insulin, glucagon, and adrenocorticotrophic hormone on the plasma glucose and free fatty acids of the domestic fowl. J Endocrinol — Hochachka PW, Neely JR, Driedzic WR Integration of lipid utilization with Krebs cycle activity in muscle. Holloszy JO, Booth FW Biochemical adaptations to endurance exercise in muscle. Annu Rev Physiol — Husbands DR The distribution of lipoprotein lipase in tissues of the domestic fowl and the effects of feeding and starving. Br J Poult Sci — John TM, George JC Influence of glucagon and neurohypophysial hormones on plasma free fatty acid levels in the pigeon. Comp Biochem Physiol A Comp Physiol — John TM, Viswanathan M, George JC, Scanes CG Flight effects on plasma levels of free fatty acids, growth hormone, and thyroid hormones in homing pigeons. Horm Metab Res — Karlsson L, Persson K, Pettersson J, Walinder G Fat-weight relationships and migratory strategies in the robin Erithacus rubecula at two stop-over sites in south Sweden. King JR The bioenergetics of vernal premigratory fat deposition in the white-crowned sparrow. King JR, Farner DS Bioenergetic basis of light-induced fat deposition in the white-crowned sparrow. PubMed Google Scholar. King JR, Murphy ME Periods of nutritional stess in the annual cycles of endotherms: fact or fiction? King JR, Barker S, Farner DS A comparison of energy reserves during autumnal and vernal migratory periods in the white-crowned sparrow, Zonotrichia leucophrys gambelii. Ecology — Langslow DR, Hales CN Lipolysis in chicken adipose tissue in vitro. Soc Exp Biol Med — Lundgren BO, Kiessling K-H Seasonal variation in catabolic enzyme activities in breast muscle of some migratory birds. Lundgren BO, Kiessling K-H Catabolic enzyme activities in the pectoralis muscle of premigratory and migratory juvenile reed warbler, Acrocephalus scirpaceus Herm. Lundgren BO, Kiessling K-H a Catabolic enzyme activities in the pectoralis muscle of migratory and non-migratory goldcrests, great tits, and yellowhammers. Ornis Scand — Lundgren BO, Kiessling K-H b Comparative aspects of fibre types, areas, and capillary supply in the pectoralis muscle of some passerine birds with differing migratory behaviour. J Comp Physiol B Biochem Syst Environ Physiol — Marsh RJ Feeding behavior of the golden-crowned sparrow, Zonotrichia atricapilla , under natural and altered photoperiods. San Jose State College, San Jose, CA. Marsh RL Catabolic enzyme activities in relation to premigratory fattening and muscle hypertrophy in the gray catbird Dumetella carolinensis. Marsh RL Adaptations of the gray catbird Dumetella carolinensis to long-distance migration: flight muscle hypertrophy associated with elevated body mass. Physiol Zool — Mattocks PW Jr The role of gonadal hormones in the regulation of the premigratory fat deposition in the white-crowned sparrow, Zonotrichia leucophrys gambelii. McGreal RD, Farner DS Premigratory fat deposition in the Gambel white-crowned sparrow: some morphological and chemical observations. Northwest Sci — Moldenhauer RR An investigation of the feeding pattern of caged white-crowned sparrows, Zonotrichia leucophrys gambelii Nuttall , in relationship to vernal fat deposition. Moore FR, Kerlinger P Stopover and fat deposition by North American wood-warblers Parulinae following spring migration over the Gulf of Mexico. Moore MC, Donham RS, Farner DS Physiological preparation for autumnal migration in white-crowned sparrows. Newsholme EA, Leech AR Biochemistry for the medical sciences. Wiley, New York, p Odum EP, Perkinson JD Jr Relation of lipid metabolism to migration in birds: seasonal variation in body lipids of the migratory white-throated sparrow. Langslow DR The action of hydrocortisone, insulin, and glucagon on chicken liver hexokinase and glucosephosphatase and on the plasma glucose and free fatty acid concentrations. CrossRef PubMed Google Scholar. Patel ST, Shah PV, Pilo B Composition of hepatic lipids during post- and premigratory periods of the migratory starling Sturnus roseus and wagtail Motacilla alba. Pavo — Pearce J Comparative aspects of lipid metabolism in avian species. Biochem Soc Trans — Peczely P Etude circanuelle de la fonction corticosurrenalienne chez les especes de passereaux migrants et non-migrants. Pettersson J, Hasselquist D Fat deposition and migratory capacity of robins Erithacus rubecula and goldcrests Regulus regulus at Ottenby, Sweden. Pilo B, George JC Diurnal and seasonal variation in liver glycogen and fat in relation to metabolic status of liver and m. pectoralis in the migratory starling. Sturnus roseus , wintering in India. Pond CM Storage. In: Townsend CR, Calow P eds Physiological ecology. Sinauer, Massachusetts, pp — Pond CM. Mattacks CA Cellular structure of adipose tissue in birds. J Morphol — Prigge WF, Grande F Effects of glucagon, epinephrine and insulin on in vitro lipolysis of adipose tissue from mammals and birds. Comp Biochem Physiol 39B— Qureshi AA, Jenik RA, Kim M, Lornitzo FA, Porter JW Separation of two active forms holo- a and holo- b of pigeon liver fatty acid synthetase and their interconversion by phosphorylation and dephosphorylation. Biochem Biophys Res Commun — Schmidt-Nielsen K Animal physiology: adaptation and environment. Cambridge University Press, Cambridge, New York, p Schwabl H, Farner DS a Dependency on testosterone of photoperiodically-induced vernal fat deposition in female white-crowned sparrows. Schwabl H, Farner DS b Endocrine and environmental control of vernal migration in male white-crowned sparrows, Zonotrichia leucophrys gambelii. Scow RO, Blanchette-Mackie EJ, Smith LC Role of capillary endothelium in the clearance of chylomicrons. A model for lipid transport from blood by lateral diffusion in cell membrane. Circ Res — Can j Zool — Stetson MH, Erickson JE Hormonal control of photoperiodically-induced fat deposition in white-crowned sparrows. Vallyathan NV On the lipid content and lipase activity in the breast muscle of Sturnus roseus Linnaeus. PAVO — Vallyathan NV, George JC Effect of exercise on lipid levels in the pigeon. Arch Int Physiol Biochem — Viswanathan M, John TM, George JC, Etches RJ Flight effects on plasma glucose, lactate, catecholamines and corticosterone in homing pigeons. Weis-Fogh T Fat combustion and metabolic rate of flying locusts Schistocerca gregaria forskål. Phil Trans R Soc Ser B — Weise GM Castration and spring migration in the white-throated sparrow. Wheeland RA, Martin RJ, Meier AH The effect of prolactin and CB on in vivo lipogenesis and enzyme patterns in the Japanese quail, Coturnix coturnix japonica , and of photostimulation on enzyme patterns in the white-throated sparrow, Zonotrichia albicollis. Comp Biochem Physiol B Comp Biochem — Yarian D, Ramenofsky M, Gray JM Corticosterone, lipid stores, and foraging behavior in dark-eyed juncos, Junco hyemalis. Am Zool Download references. Department of Zoology, NJ University of Washington, Seattle, Washington, , USA. You can also search for this author in PubMed Google Scholar. Max-Planck-Institut für Verhaltensphysiologie Vogelwarte, D, Andechs, Germany. Reprints and permissions. Ramenofsky, M. Fat Storage and Fat Metabolism in Relation to Migration. In: Gwinner, E. eds Bird Migration. Springer, Berlin, Heidelberg. Publisher Name : Springer, Berlin, Heidelberg. Print ISBN : Online ISBN : eBook Packages : Springer Book Archive. Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Policies and ethics. Skip to main content. Abstract The pivotal role played by fat in suppyling energy for migration in birds has been appreciated for nearly 4 decades and reviewed extensively Odum and Perkinson ; King and Farner ; Berthold ; Blem , ; Dawson et al. Keywords Lipoprotein Lipase Fatty Acid Synthesis Flight Muscle Stopover Site Garden Warbler These keywords were added by machine and not by the authors. Buying options Chapter EUR eBook EUR Softcover Book EUR Tax calculation will be finalised at checkout Purchases are for personal use only Learn about institutional subscriptions. Preview Unable to display preview. References Allen WV Biochemical aspects of lipid storage and utilization in animals. Am Zool — CAS Google Scholar Annison EF Lipid metabolism. Please view the glossary at the bottom of this page for definition of relevant biochemical terms. The major fuel store of the body is triglyceride or TAG in adipose tissue. Glycogen in liver and muscle is more of a short-term store of carbohydrates. From the above animations, we can see how these molecules play an interconnected role to provide energy or be stored at different times. But during metabolic diseases like diabetes or obesity these processes do not occur optimally. An example is formation of triglycerides from fatty acids and glycerol. FATTY ACIDS: are building blocks of lipid molecules such as fats. They can be obtained both through diet or breakdown of stored fats in the body. They are insoluble in water and therefore transported in complex particles called lipoproteins. The excess fatty acids and cholesterol in the liver are converted to their respective esters and packaged with proteins into VLDL. Keith N. Metabolic Regulation: A Human Perspective. Hoboken: John Wiley and Sons, Inc. Denise R. Lippincott Illustrated Reviews: Biochemistry. Philadelphia: Wolters Kluwer. Liangyou Rui. Energy Metabolism in the Liver. Compr Physiol. Glatz and Luiken. |
| Too Much Protein Can Make You Fat | Fat stores can build up, leading to obesity and related health problems. Fat tissue does more than just store energy. To learn about some of the more active roles of fat, visit The Friendly Side of Fat. The protein in our food supplies amino acids that we need for replacing proteins lost in urine, in shed hair and skin, and through other means. Because we can't store protein for the long-term, we need to eat some every day especially the 9 "indispensible" or essential amino acids that our cells cannot make from other nutrients. The amount of protein we need to eat to replace what we lose is relatively modest. Any protein we eat beyond what we need for rebuilding is burned for energy, converted to sugar, or most commonly converted to fat. While some of the protein from our food becomes protein in our bodies, eating a high-protein diet will not necessarily help the body build more muscle protein. Mostly it just builds fat. A number of diets recommend eating high amounts of protein, and some evidence suggests that for people trying to lose weight a high-protein diet reduces hunger and food cravings. But regardless of what we eat, weight loss will only occur when we burn more calories than we consume. When a high-protein diet contains more calories than we need, the excess still builds up as fat. Sugars consumed in excess are also readily converted to fat for storage. To learn more, visit Spotlight on Sugar. The protein from our food doesn't necessarily become protein in our bodies. Our cells can burn amino acids as fuel and convert them into sugar and fat. Because food has not always been readily available, humans and other animals have evolved ways to store fuel reserves in their bodies. When food is plentiful, the body packs away extra calories in fat reserves. The stored fat fuels the body when food is scarce. But why does the body go through the trouble of converting amino acids and sugars to fat for storage? Wouldn't it make more sense to store more proteins and glycogen? It turns out that fat is a much more efficient way to store energy. Fat has about 9 calories per gram, and protein and carbohydrate have just 4. In living tissue, this difference is even greater. It seems that oestrogens and androgens help to decide body fat distribution. Oestrogens are sex hormones made by the ovaries in pre-menopausal women. They are responsible for prompting ovulation every menstrual cycle. Men and postmenopausal women do not produce much oestrogen in their testes testicles or ovaries. Instead, most of their oestrogen is produced in their body fat, although at much lower amounts than what is produced in pre-menopausal ovaries. In younger men, androgens are produced at high levels in the testes. As a man gets older, these levels gradually decrease. The changes with age in the sex hormone levels of both men and women are associated with changes in body fat distribution. Animal studies have also shown that a lack of oestrogen leads to excessive weight gain. The pituitary gland in our brain produces growth hormone, which influences a person's height and helps build bone and muscle. Growth hormone also affects metabolism the rate at which we burn kilojoules for energy. Researchers have found that growth hormone levels in people who are obese are lower than in people of normal weight. Obesity is also associated with low-grade chronic inflammation within the fat tissue. Excessive fat storage leads to stress reactions within fat cells, which in turn lead to the release of pro-inflammatory factors from the fat cells themselves and immune cells within the adipose fat tissue. Obesity is associated with an increased risk of a number of diseases, including cardiovascular disease, stroke and several types of cancer, and with decreased longevity shorter life span and lower quality of life. For example, the increased production of oestrogens in the fat of older women who are obese is associated with an increase in breast cancer risk, indicating that the source of oestrogen production is important. People who are obese have hormone levels that encourage the accumulation of body fat. It seems that behaviours such as overeating and lack of regular exercise, over time, 'reset' the processes that regulate appetite and body fat distribution to make the person physiologically more likely to gain weight. The body is always trying to maintain balance, so it resists any short-term disruptions such as crash dieting. Various studies have shown that a person's blood leptin level drops after a low-kilojoule diet. Lower leptin levels may increase a person's appetite and slow down their metabolism. This may help to explain why crash dieters usually regain their lost weight. It is possible that leptin therapy may one day help dieters to maintain their weight loss in the long term, but more research is needed before this becomes a reality. There is evidence to suggest that long-term behaviour changes, such as healthy eating and regular exercise, can re-train the body to shed excess body fat and keep it off. Studies have also shown that weight loss as a result of healthy diet and exercise or bariatric surgery leads to improved insulin resistance, decreased inflammation and beneficial modulation of obesity hormones. Weight loss is also associated with a decreased risk of developing heart disease, stroke, type II diabetes and some cancers. This page has been produced in consultation with and approved by:. Acromegaly is caused by an excess of growth hormone in adults, which causes the overgrowth of bones in the face, hands, feet and internal organs. The effects of androgen deficiency depend on how severe the deficiency is, its cause and the age at which the deficiency begins. Bairlein F a Body weights and fat deposition of Palaearctic passerine migrants in the central Sahara. Oecologia Berl — CrossRef Google Scholar. Bairlein F b Efficiency of food utilization during fat deposition in the long-distance migratory garden warbler, Sylvia borin. Ballantyne JS, John TM, George JC The effects of glucagon on hepatic mitochondrial metabolism in the pigeon, Columba livia. Gen Comp Endocrinol — CrossRef PubMed CAS Google Scholar. Bensadoun A, Kompiang IP Role of lipoprotein lipase in plasma triglyceride removal. Fed Proc — PubMed CAS Google Scholar. Bensadoun A, Rothfield A The form of absorption of lipids in the chicken, Gallus domesticus. Proc Soc Exp Biol Med — Benson JD, Bensadoun A, Cohen D Lipoprotein lipase of ovarian follicles in the domestic chicken Gallus domesticus. Berthold P Migration: control and metabolic physiology. In: Farner DS, King JR eds Avian biology, vol 5. Academic Press, London, pp 77— Berthold P Physiology and genetics of avian migration. In: Rankin MA ed Migration: mechanisms and adaptive significance. Contributions in Marine Science. University of Texas, Austin, Port Aransas, Texas, pp — Biebach H Sahara stopover in migratory flycatchers: fat and food affect the time program. Experientia Basel — Biebach H, Friedrich W, Heine G Interaction of body mass, fat, foraging and stopover period in trans-Sahara migrating passerine birds. Blem CR Patterns of lipid storage and utilization in birds. Blem CR The energetics of migration. In: Gauthreaux SA ed Animal migration, orientation, and navigation. Borensztajn J Lipoprotein lipase. Evener, Chicago, p Carey C, Dawson WR, Maxwell LC, Faulkner JA Seasonal acclimatization to temperature in cardueline finches. Changes in body composition and mass in relation to season and acute cold stress. J Comp Physiol — Chaffee RRJ, Mayhew WW Studies on chemical thermoregulation in the house sparrow Passer domesticus. Can J Physiol Pharmacol — Chan BL, Lisanti MP, Rodriguez-Boulan E, Saltiei AR Insulin-stimulated release of lipoprotein lipase by metabolism of its phosphatidylinositol anchor. Science — Chandrabose KA, Bensadoun A Effect of hypophysectomy on some enzymes involved in lipid metabolism of the domestic chicken Gallus domesticus. Comp Biochem Physiol — Cherry JD Fat deposition and length of stopover of migrant white-crowned sparrows. Auk — Dawson WR, Marsh RL, Yacoe ME Metabolic adjustments of small passerine birds for migration and cold. Am J Physiol R— De Graw WA Seasonal changes in liver malic enzyme activity in white-crowned sparrows, Zonotrichia leucophrys gambelli. Proc Nebr Acad Sci Affil Soc 85th Annu Meet, p Dolnik V, Blyumental TI Autumnal premigratory and migratory periods in the chaffinch Fringilla coelebs coelebs and some other temperate-zone birds. Condor — Donaldson WE Regulation of fatty acid synthesis. Eckel RH Adipose tissue lipoprotein lipase. In: Borensztajn J ed Lipoprotein lipase. Evener, Chicago, pp 79— Evans PR Winter fat deposition and overnight survival of yellow buntings Emberiza citrinella L. J Anim Ecol — Farner DS, Oksche A, Kamemoto FI, King JR, Cheyney HE A comparison of the effect of long daily photoperiods on the pattern of energy storage in migratory and nonmigratory finches. Filippo G de, Milone M, Esposito R, Caliendo MF Winter and premigratory lipid metabolism in Erithacus r. Abstract from 14th Conference of European Comparative Endocrinologists, University of Salzberg, Austria, September 4—9. Florant G, Greenwood MRC Seasonal variations in pancreatic function in marmots: the role of pancreatic hormones and lipoprotein lipase in fat deposition. In: Heller HC, Musacchia XJ, Wang LCH eds Living in the cold: physiological and biochemical adaptations. Elsevier Science, New York, pp — Fried SK, Hill JO, Nickel M, DiGirolamo M Prolonged effects of fasting-refeeding on rat adipose tissue lipoprotein lipase activity: influence of caloric restriction during refeeding. J Nutr — Fry CH, Ash JKS, Ferguson-Lees IJ Spring weights of some Palaearctic migrants at Lake Chad. Ibis — Fry CH, Ferguson-Lees IF, Dowsett RJ Flight muscle hypertrophy and ecophysiological variation of yellow wagtail Motacilla flava races at Lake Chad. J Zool Lond — Garfinkel AS, Baker N, Schotz MC Relationship of lipoprotein lipase activity to triglyceride uptake in adipose tissue. J Lipid Res — Garrett RL, Young RJ Effect of micelle formation on the absorption of neutral fat and fatty acids by the chicken. George JC, Vallyathan NV Lipase and succinic dehydrogenase activity of the particulate fractions of the breast muscle homogenate of the migratory starling Sturnus roseus in the pre-migratory and post-migratory periods. J Cell Comp Physiol — CrossRef CAS Google Scholar. Gibson WR, Nalbandov AV Lipolysis and lipogenesis in liver and adipose tissue of hypo-physectomized cockerels. Am J Physiol 6 : — Gifford CE, Odum EP Bioenergetics of lipid deposition in the bobolink, a transequatorial migrant. Goodridge AG Regulation of the activity of acetyl coenzyme A carboxylase by palmitoyl coenzyme A and citrate. J Biol Chem — Goodridge AG Hormonal regulation of the activity of the fatty acid synthesizing system and of the malic enzyme concentration in liver cells. Goodridge AG Fatty acid synthesis in eucaryotes. In: Vance DE, Vance JE eds Biochemistry of lipids and membranes. Goodridge AG, Ball EG Studies on the metabolism of adipose tissue XVIII. In vitro effects of insulin, epinephrine, and glucagon on lipolysis and glycolysis in pigeon adipose tissue. Goodridge AG, Ball EG Lipogenesis in the pigeon: in vitro studies. Am J Physiol — Goodridge AG, Ball EG The effect of prolactin on lipogenesis in the pigeon: in vitro studies. Biochemistry — Goodridge AG, Crish JF, Hillgartner FB, Wilson SB Nutritional and hormonal regulation of the gene for avian malic enzyme. Gornall DA, Kuksis A, Morley N Lipid-metabolizing enzymes in the ovary of the laying hen. Biochim Biophys Acta — Grande F Effect of glucagon on plasma free fatty acids and blood sugar in birds. Grande F Effect of catecholamines on plasma free fatty acids and blood sugar in birds. Grande F, Prigge WF Glucagon infusion, plasma FFA and triglycerides, blood sugar and liver lipids in birds. Gray JM, Yarian D, Ramenofsky M Corticosterone, foraging behavior, and metabolism in dark-eyed juncos Junco hyemalis. Gen Comp Endocrinol, in press. Metabolism — Gwinner E, Biebach H, Kries I Food availability affects migratory restlessness in caged garden warblers Sylvia borin. Naturwissenschaften Hamosh M, Hamosh P Lipoprotein lipase: its physiological and clinical significance. Mol Aspects Med — Hazelwood RL Endocrine control of avian carbohydrate metabolism. Poult Sci — Heald PJ, McLaughlan PM, Rookledge KA The effects of insulin, glucagon, and adrenocorticotrophic hormone on the plasma glucose and free fatty acids of the domestic fowl. J Endocrinol — Hochachka PW, Neely JR, Driedzic WR Integration of lipid utilization with Krebs cycle activity in muscle. Holloszy JO, Booth FW Biochemical adaptations to endurance exercise in muscle. Annu Rev Physiol — Husbands DR The distribution of lipoprotein lipase in tissues of the domestic fowl and the effects of feeding and starving. Br J Poult Sci — John TM, George JC Influence of glucagon and neurohypophysial hormones on plasma free fatty acid levels in the pigeon. Comp Biochem Physiol A Comp Physiol — John TM, Viswanathan M, George JC, Scanes CG Flight effects on plasma levels of free fatty acids, growth hormone, and thyroid hormones in homing pigeons. Horm Metab Res — Karlsson L, Persson K, Pettersson J, Walinder G Fat-weight relationships and migratory strategies in the robin Erithacus rubecula at two stop-over sites in south Sweden. King JR The bioenergetics of vernal premigratory fat deposition in the white-crowned sparrow. |
Video
You Gotta Learn To Burn Fat As Fuel Bro We may Metbaolism appreciate body Metabolism and fat storage, adn when it accumulates in specific areas like our bellies or thighs. Within storabe matrix of Resupply tracking solutions fat, also called Non-toxic allergen control tissue, Metabolism and fat storage is not only fat cells but nerve and immune cells and connective tissue. Macrophages, neutrophils, and eosinophils are some of the immune cells found in fat tissue that play a role in inflammation—both anti-inflammatory and proinflammatory. Fat cells also secrete proteins and build enzymes involved with immune function and the creation of steroid hormones. Fat cells can grow in size and number.Metabolism and fat storage -
Insulin, a hormone produced by the pancreas, is important for the regulation of carbohydrates and the metabolism of fat. Insulin stimulates glucose sugar uptake from the blood in tissues such as muscles, the liver and fat.
This is an important process to make sure that energy is available for everyday functioning and to maintain normal levels of circulating glucose. In a person who is obese, insulin signals are sometimes lost and tissues are no longer able to control glucose levels.
This can lead to the development of type II diabetes and metabolic syndrome. Body fat distribution plays an important role in the development of obesity-related conditions such as heart disease, stroke and some forms of arthritis.
Fat around our abdomen is a higher risk factor for disease than fat stored on our bottom, hips and thighs. It seems that oestrogens and androgens help to decide body fat distribution.
Oestrogens are sex hormones made by the ovaries in pre-menopausal women. They are responsible for prompting ovulation every menstrual cycle.
Men and postmenopausal women do not produce much oestrogen in their testes testicles or ovaries. Instead, most of their oestrogen is produced in their body fat, although at much lower amounts than what is produced in pre-menopausal ovaries. In younger men, androgens are produced at high levels in the testes.
As a man gets older, these levels gradually decrease. The changes with age in the sex hormone levels of both men and women are associated with changes in body fat distribution.
Animal studies have also shown that a lack of oestrogen leads to excessive weight gain. The pituitary gland in our brain produces growth hormone, which influences a person's height and helps build bone and muscle.
Growth hormone also affects metabolism the rate at which we burn kilojoules for energy. Researchers have found that growth hormone levels in people who are obese are lower than in people of normal weight.
Obesity is also associated with low-grade chronic inflammation within the fat tissue. Excessive fat storage leads to stress reactions within fat cells, which in turn lead to the release of pro-inflammatory factors from the fat cells themselves and immune cells within the adipose fat tissue.
Obesity is associated with an increased risk of a number of diseases, including cardiovascular disease, stroke and several types of cancer, and with decreased longevity shorter life span and lower quality of life. For example, the increased production of oestrogens in the fat of older women who are obese is associated with an increase in breast cancer risk, indicating that the source of oestrogen production is important.
People who are obese have hormone levels that encourage the accumulation of body fat. It seems that behaviours such as overeating and lack of regular exercise, over time, 'reset' the processes that regulate appetite and body fat distribution to make the person physiologically more likely to gain weight.
The body is always trying to maintain balance, so it resists any short-term disruptions such as crash dieting. Various studies have shown that a person's blood leptin level drops after a low-kilojoule diet.
Lower leptin levels may increase a person's appetite and slow down their metabolism. This may help to explain why crash dieters usually regain their lost weight. It is possible that leptin therapy may one day help dieters to maintain their weight loss in the long term, but more research is needed before this becomes a reality.
There is evidence to suggest that long-term behaviour changes, such as healthy eating and regular exercise, can re-train the body to shed excess body fat and keep it off. Studies have also shown that weight loss as a result of healthy diet and exercise or bariatric surgery leads to improved insulin resistance, decreased inflammation and beneficial modulation of obesity hormones.
Weight loss is also associated with a decreased risk of developing heart disease, stroke, type II diabetes and some cancers. This page has been produced in consultation with and approved by:. Acromegaly is caused by an excess of growth hormone in adults, which causes the overgrowth of bones in the face, hands, feet and internal organs.
The effects of androgen deficiency depend on how severe the deficiency is, its cause and the age at which the deficiency begins. Androgens are hormones that contribute to growth and reproduction in both men and women.
A kilojoule is a unit of measure of energy, in the same way that kilometres measure distance. Body mass index or BMI is an approximate measure of your total body fat. Content on this website is provided for information purposes only. Information about a therapy, service, product or treatment does not in any way endorse or support such therapy, service, product or treatment and is not intended to replace advice from your doctor or other registered health professional.
The information and materials contained on this website are not intended to constitute a comprehensive guide concerning all aspects of the therapy, product or treatment described on the website. All users are urged to always seek advice from a registered health care professional for diagnosis and answers to their medical questions and to ascertain whether the particular therapy, service, product or treatment described on the website is suitable in their circumstances.
This occurs in the same way as in the liver, except that these tissues do not release the triglycerides thus produced as VLDL into the blood.
All cells in the body need to manufacture and maintain their membranes and the membranes of their organelles. Whether they rely entirely on free fatty acids absorbed from the blood, or are able to synthesize their own fatty acids from blood glucose, is not known.
The cells of the central nervous system will almost certainly have the capability of manufacturing their own fatty acids, as these molecules cannot reach them through the blood brain barrier.
Much like beta-oxidation , straight-chain fatty acid synthesis occurs via the six recurring reactions shown below, until the carbon palmitic acid is produced.
The diagrams presented show how fatty acids are synthesized in microorganisms and list the enzymes found in Escherichia coli. FASII is present in prokaryotes , plants, fungi, and parasites, as well as in mitochondria.
In animals as well as some fungi such as yeast, these same reactions occur on fatty acid synthase I FASI , a large dimeric protein that has all of the enzymatic activities required to create a fatty acid. FASI is less efficient than FASII; however, it allows for the formation of more molecules, including "medium-chain" fatty acids via early chain termination.
by transferring fatty acids between an acyl acceptor and donor. They also have the task of synthesizing bioactive lipids as well as their precursor molecules. Elongation, starting with stearate , is performed mainly in the endoplasmic reticulum by several membrane-bound enzymes.
The enzymatic steps involved in the elongation process are principally the same as those carried out by fatty acid synthesis , but the four principal successive steps of the elongation are performed by individual proteins, which may be physically associated.
Abbreviations: ACP — Acyl carrier protein , CoA — Coenzyme A , NADP — Nicotinamide adenine dinucleotide phosphate. Note that during fatty synthesis the reducing agent is NADPH , whereas NAD is the oxidizing agent in beta-oxidation the breakdown of fatty acids to acetyl-CoA. This difference exemplifies a general principle that NADPH is consumed during biosynthetic reactions, whereas NADH is generated in energy-yielding reactions.
The source of the NADPH is two-fold. NADPH is also formed by the pentose phosphate pathway which converts glucose into ribose, which can be used in synthesis of nucleotides and nucleic acids , or it can be catabolized to pyruvate.
In humans, fatty acids are formed from carbohydrates predominantly in the liver and adipose tissue , as well as in the mammary glands during lactation.
The pyruvate produced by glycolysis is an important intermediary in the conversion of carbohydrates into fatty acids and cholesterol. However, this acetyl CoA needs to be transported into cytosol where the synthesis of fatty acids and cholesterol occurs.
This cannot occur directly. To obtain cytosolic acetyl-CoA, citrate produced by the condensation of acetyl CoA with oxaloacetate is removed from the citric acid cycle and carried across the inner mitochondrial membrane into the cytosol.
The oxaloacetate is returned to mitochondrion as malate and then converted back into oxaloacetate to transfer more acetyl-CoA out of the mitochondrion. Acetyl-CoA is formed into malonyl-CoA by acetyl-CoA carboxylase , at which point malonyl-CoA is destined to feed into the fatty acid synthesis pathway.
Acetyl-CoA carboxylase is the point of regulation in saturated straight-chain fatty acid synthesis, and is subject to both phosphorylation and allosteric regulation. Regulation by phosphorylation occurs mostly in mammals, while allosteric regulation occurs in most organisms.
Allosteric control occurs as feedback inhibition by palmitoyl-CoA and activation by citrate. When there are high levels of palmitoyl-CoA, the final product of saturated fatty acid synthesis, it allosterically inactivates acetyl-CoA carboxylase to prevent a build-up of fatty acids in cells.
Citrate acts to activate acetyl-CoA carboxylase under high levels, because high levels indicate that there is enough acetyl-CoA to feed into the Krebs cycle and produce energy. High plasma levels of insulin in the blood plasma e. after meals cause the dephosphorylation and activation of acetyl-CoA carboxylase, thus promoting the formation of malonyl-CoA from acetyl-CoA, and consequently the conversion of carbohydrates into fatty acids, while epinephrine and glucagon released into the blood during starvation and exercise cause the phosphorylation of this enzyme, inhibiting lipogenesis in favor of fatty acid oxidation via beta-oxidation.
Disorders of fatty acid metabolism can be described in terms of, for example, hypertriglyceridemia too high level of triglycerides , or other types of hyperlipidemia. These may be familial or acquired. Familial types of disorders of fatty acid metabolism are generally classified as inborn errors of lipid metabolism.
These disorders may be described as fatty acid oxidation disorders or as a lipid storage disorders , and are any one of several inborn errors of metabolism that result from enzyme or transport protein defects affecting the ability of the body to oxidize fatty acids in order to produce energy within muscles, liver, and other cell types.
When a fatty acid oxidation disorder affects the muscles, it is a metabolic myopathy. Moreover, cancer cells can display irregular fatty acid metabolism with regard to both fatty acid synthesis [44] and mitochondrial fatty acid oxidation FAO [45] that are involved in diverse aspects of tumorigenesis and cell growth.
Contents move to sidebar hide. Article Talk. Read Edit View history. Tools Tools. What links here Related changes Upload file Special pages Permanent link Page information Cite this page Get shortened URL Download QR code Wikidata item.
Download as PDF Printable version. Set of biological processes. Main article: Fatty acid synthesis. Main article: Citric acid cycle § Glycolytic end products are used in the conversion of carbohydrates into fatty acids. In: Biochemistry Fourth ed. New York: W.
Freeman and Company. ISBN doi : PMID S2CID Pflügers Archiv: European Journal of Physiology. Molecular Aspects of Medicine. PMC Jul J Neurosci. Feb J Cereb Blood Flow Metab.
Biochemistry Fourth ed. Donald; Stafstrom, Carl E. ISSN Molecular Genetics and Metabolism. W; Koeslag, J. European Journal of Applied Physiology. Toxicol Appl Pharmacol. Invited review. Nigerian Journal of Physiological Science.
Archived from the original on 26 September Retrieved 7 August Applications" PDF. Biotechnology and Bioengineering. Ann NY Acad Sci. Bibcode : NYASA. Vander Jagt; B. Robinson; K. Taylor; L. Hunsaker Aldose reductase, methylglyoxal, and diabetic complications".
The Journal of Biological Chemistry. An introduction to behavioral endocrinology 3rd ed. Sunderland, Mass: Sinauer Associates. The solvent properties of dilute micellar solutions of conjugated bile salts". Gropper, Jack L. Advanced nutrition and human metabolism 6th ed.
In: Gray's Anatomy Thirty-seventh ed. Edinburgh: Churchill Livingstone. European Journal of Biochemistry. Hamilton, and Wolf Hamm.
Oxford: Blackwell Pub. MetaCyc Metabolic Pathway Database. In American Oil Chemists' Society ed. AOCS Lipid Library. Archived from the original on Retrieved Progress in Lipid Research. Foufelle Hormone Research.
Voet; Charlotte W. Pratt Fundamentals of Biochemistry, 2nd Edition. John Wiley and Sons, Inc. Life Sciences. Journal of Physiology and Biochemistry.
Inborn error of lipid metabolism : fatty-acid metabolism disorders. Biotinidase deficiency BTD. Carnitine CPT1 CPT2 CDSP CACTD Adrenoleukodystrophy ALD. Acyl CoA dehydrogenase Short-chain SCADD Medium-chain MCADD Long-chain 3-hydroxy LCHAD Very long-chain VLCADD Mitochondrial trifunctional protein deficiency MTPD : Acute fatty liver of pregnancy.
Propionic acidemia PCC deficiency. Malonic aciduria MCD. Sjögren—Larsson syndrome SLS. Metabolism , catabolism , anabolism. Metabolic pathway Metabolic network Primary nutritional groups.
Purine metabolism Nucleotide salvage Pyrimidine metabolism Purine nucleotide cycle. Pentose phosphate pathway Fructolysis Polyol pathway Galactolysis Leloir pathway.
Glycosylation N-linked O-linked. Photosynthesis Anoxygenic photosynthesis Chemosynthesis Carbon fixation DeLey-Doudoroff pathway Entner-Doudoroff pathway. Xylose metabolism Radiotrophism.
Fatty acid degradation Beta oxidation Fatty acid synthesis. Steroid metabolism Sphingolipid metabolism Eicosanoid metabolism Ketosis Reverse cholesterol transport. Metal metabolism Iron metabolism Ethanol metabolism Phospagen system ATP-PCr. Metabolism map.
Carbon fixation. Photo- respiration. Pentose phosphate pathway. Citric acid cycle. Glyoxylate cycle. Urea cycle. Fatty acid synthesis.
Fatty acid elongation. Beta oxidation. beta oxidation. Glyco- genolysis. Glyco- genesis. Glyco- lysis. Gluconeo- genesis. Pyruvate decarb- oxylation. Keto- lysis. Keto- genesis. feeders to gluconeo- genesis.
Light reaction. Oxidative phosphorylation.
Bulletin of the Metabolism and fat storage Research Centre volume 43Sforage number: Cite this article. Metrics details. Adipose tissue Organic coffee beans a type of connective tissue Coenzyme Q levels storwge adipocytes. Storagee, this tissue has been recognized as a major endocrine organ. The physiological process of fat loss occurs when fats are liberated from adipocytes into circulation to supply the needed energy. Nutrition supplements that increase fat metabolism, impair fat absorption, increase weight loss, and increase fat oxidation during exercise are known as fat burners.
0 thoughts on “Metabolism and fat storage”